Savant Capital LLC Acquires 119,299 Shares of DENTSPLY SIRONA Inc. $XRAY

Savant Capital LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 92.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 248,533 shares of the medical instruments supplier’s stock after purchasing an additional 119,299 shares during the period. Savant Capital LLC’s holdings in DENTSPLY SIRONA were worth $3,154,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. AQR Capital Management LLC raised its holdings in shares of DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares in the last quarter. Lazard Asset Management LLC grew its position in DENTSPLY SIRONA by 8.0% in the second quarter. Lazard Asset Management LLC now owns 10,107,657 shares of the medical instruments supplier’s stock valued at $160,508,000 after acquiring an additional 745,421 shares during the period. State Street Corp raised its stake in DENTSPLY SIRONA by 5.5% during the second quarter. State Street Corp now owns 7,099,906 shares of the medical instruments supplier’s stock worth $113,868,000 after acquiring an additional 369,876 shares in the last quarter. Edmond DE Rothschild Holding S.A. lifted its holdings in shares of DENTSPLY SIRONA by 6.0% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 3,087,300 shares of the medical instruments supplier’s stock valued at $49,026,000 after acquiring an additional 173,900 shares during the period. Finally, Norges Bank acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at $39,700,000. Institutional investors own 95.70% of the company’s stock.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Stock Up 9.8%

NASDAQ XRAY opened at $13.76 on Friday. The stock has a market capitalization of $2.74 billion, a P/E ratio of -3.11, a price-to-earnings-growth ratio of 1.11 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 52 week low of $9.85 and a 52 week high of $19.27. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The stock has a fifty day moving average of $11.90 and a 200-day moving average of $12.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The company’s revenue was down 4.9% compared to the same quarter last year. During the same period last year, the company earned $0.50 EPS. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.48%.

Analyst Ratings Changes

A number of brokerages recently issued reports on XRAY. JPMorgan Chase & Co. dropped their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, November 7th. Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Finally, Mizuho raised their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Tuesday, January 20th. Two investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $14.25.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.